Chinese RISC-V Chipmaker Eswin Targets US$300 Million Hong Kong IPO as Domestic Chip Industry Accelerates

The Quick Take

• Beijing Eswin Computing Technology is seeking to raise approximately US$300 million in a Hong Kong IPO, becoming one of China's first RISC-V architecture chipmakers to access public markets
• The listing signals growing investor appetite for Chinese semiconductor companies building on open-source chip architectures as an alternative to US-controlled x86 and ARM ecosystems
• Eswin's IPO follows a wave of Chinese chip company listings aimed at funding domestic alternatives to foreign-controlled semiconductor IP amid ongoing US export restrictions

Beijing Eswin Computing Technology's planned US$300 million Hong Kong IPO positions the company at the intersection of two dominant investment themes: China's accelerated push for semiconductor self-sufficiency and the global rise of RISC-V, the open-source chip instruction set architecture that offers an alternative to proprietary ARM and x86 designs controlled by US companies. RISC-V's open-source license structure makes it uniquely attractive for Chinese chipmakers seeking to build architectures free of US IP restrictions — a strategic advantage that has attracted significant government and venture backing for the Chinese RISC-V ecosystem. Eswin's listing follows SOPHGO, Canaan Inc., and other Chinese chip companies that have tapped public markets to fund design and manufacturing scale-up.

The HK listing venue is notable: HKEX has positioned itself as the preferred capital raising destination for Chinese tech companies facing dual-listing restrictions in US markets under the HOLDING Act scrutiny framework. For Hong Kong's equity market, Eswin's IPO adds to a pipeline of Chinese semiconductor listings that have outperformed the broader Hang Seng index on national strategic relevance sentiment. Institutional investors with access to Chinese semiconductor allocations — including sovereign funds and technology-sector growth funds — are watching this listing as a benchmark for how public markets value privately-held RISC-V startups, which currently number in the dozens in China's chip ecosystem.

Forward signals include the institutional book-building outcome and IPO pricing relative to pre-IPO valuation — oversubscription and premium pricing would signal strong market confidence in Chinese domestic chip alternatives. The macro variable is the trajectory of US export controls: any expansion of restrictions on advanced semiconductor IP or EDA tools would increase the strategic premium investors assign to companies building entirely on open-source architectures. Investors should also watch Eswin's post-IPO product revenue ramp, since many Chinese chip startups have successfully raised capital but face challenges scaling from design wins to mass production volumes that justify public-market valuations.

Synthesized from 1 source.